Pharmaceutical compounds
US8987260B2 · kind B2 · utility
1Cited by
14References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 6, 2014 |
| Grant date | Mar 24, 2015 |
| Priority date | — |
| Expiry date | Feb 6, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein is a pharmaceutical composition that comprises a pharmaceutically acceptable carrier or diluent and, as an active ingredient, the compound 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine bismesylate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.